Saneca Pharmaceuticals stock traded at EUR 20.3 per share at the end 2019 translating into a market capitalization of USD 22.8 mil.
Since the end of 2014, stock has appreciated by 0% representing an annual average growth of %. In absolute terms, the value of the company rose by USD 22.8 mil.
At the end of 2019, the firm traded at price to earnings of -5.64x. Over the last five years, this multiple achieved a high of -5.64x in 2019 and a low of -5.64x in 2019 with an average of -5.64x.
In terms of EV/EBITDA, stock traded at -17.2x at the end of 2019. Since 2014, stock has traded between -17.2x and 9.77x with an average of -3.70x.
You can see all the company’s data at Saneca Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
